Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics
Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics
Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics
Submitted by
admin
on March 5, 2015 - 8:08am
Source:
Forbes
News Tags:
AbbVie
Pharmacyclics
M&A
Headline:
Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics
Do Not Allow Advertisers to Use My Personal information
